• Aslan AT, Tanriverdi ES, Kaya SY, Dalgan G, Saltoğlu N, Yılmaz E, Çiçek Y, Yılmaz M, Erol Ç, Azap ÖK, Hazırolan G, Dağ O, Yüce ZT, Sagiroglu P, Boztaş D, Işık MC, Otlu B, Harris PNA, Paterson DL, Akova M; Study Group for Carbapenem Resistance (SCARE). Comparison of ceftazidime-avibactam with other appropriate antimicrobial therapy for the treatment of OXA-48- or KPC-producing Enterobacterales infections in Türkiye: A multi-centre retrospective matched-cohort study. Int J Antimicrob Agents. 2026 Jan;67(1):107650.

           https://pubmed.ncbi.nlm.nih.gov/41161581/

• Boşnak C, Akova M. Sepsis in the older intensive care unit patient: current insights and nursing priorities. Intensive Crit Care Nurs. 2026 Feb;92:104249.

           https://pubmed.ncbi.nlm.nih.gov/41092594/

• Tas A, Silindir-Günay M, Calamak S, Nigiz S, Inkaya AC. Development, characterization, and in vitro evaluation of co-drug encapsulated, targeted theranostic liposomes for osteomyelitis. J Radioanal Nuclear Chem, Jan 12,2026. 

           https://doi.org/10.1007/s10967-025-10708-9

• Buran S, Tüfekçi O, Sarı EO, Damar-Örenler S, Damar-Çakırca T, Akgöz A, Besler-Tuncer A, Yakut Y, Karaca NB, Uzun M, Sönmezer MÇ, İnkaya AÇ, Ünal S, Ünal E. Assessing biopsychosocial status in people living with HIV: validity, reliablity, and respnsiveness of BETY-BQ. BMC Infect Dis Jan 12, 2026. 

           https://pubmed.ncbi.nlm.nih.gov/41526851/

• Tanriover MD, Poulimeneas D, Tsopela GC, Kopsidas I, Argyropoulos C, Di Marzo R, Valdenmaiier O, Jakobsen SF, Valle Simon P, Carcas-Sansuan AJ, Olesen OF, Cornely OA, Pana ZD, Zaoutis T, Akova M. Barriers and Opportunities to Include Underrepresented Population Groups in Vaccine Trials: Cross-Sectional, Observational, Online Survey Study From the VACCELERATE Research Network. JMIR Public Health Surveill. 2026 Apr 7;12:e89025.

           https://pubmed.ncbi.nlm.nih.gov/41945868/

• Ergönül Ö, Akova M. Influenza Pandemics After COVID-19: Still a Credible Threat in a Broader Pandemic Landscape. Infect Dis Clin Microbiol. 2026 Jan 30;8(1):120-122.

           https://pubmed.ncbi.nlm.nih.gov/41809928/

• Stemler J, Yeghiazaryan L, Stephan C, Greve-Isdahl Mohn K, Cox RJ, Carcas-Sansuan AJ, Romero Rodriguez E, Moltó J, Vergara Mitxeltorena I, Pink I, Welte T, Zablockienė B, Akova M, Bethe U, Grimm S, Salmanton-García J, Jakobs J, Tischmann L, Zarrouk M, Cüppers A, Biehl LM, Grothe J, Mellinghoff SC, Nacov JA, Neuhann JM, Sprute R, Frías-Iniesta J, Negi R, Gaillard C, Saini G, León AG, Mallon PWG, Lammens C, Hotterbeekx A, Loens K, Malhotra-Kumar S, Goossens H, Kumar-Singh S, König F, Posch M, Koehler P, Cornely OA; EU-COVAT-1 AGED study group on behalf of the VACCELERATE Consortium. Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED)-final report. Int J Infect Dis. 2026 Apr;165:108466. 

           https://pubmed.ncbi.nlm.nih.gov/41655623/

• Klyasova G, Solopova G, Abdalla J, Popova M, Ar MC, Sungur M, Fakih RE, Almaghrabi RS, Akova M. Early Antifungal Treatment in Immunocompromised Patients, Including Hematological and Critically Ill Patients. J Fungi (Basel). 2026 Jan 13;12(1):59.

           https://pubmed.ncbi.nlm.nih.gov/41590471/

• Balaban U, Kara E, Pinar A, Gulmez D, Aladag Karakulak E, Arikan Akdagli S, Uzun O, Metan G. Posaconazole Therapeutic Drug Monitoring in Daily Practice: A Single-Center Analysis. Indian J Hematol Blood Transfus. 2026 May;42(3):818-825.

            https://pubmed.ncbi.nlm.nih.gov/42040675/

• Kara E, Sahin N, Yumrucu FG, Metan G. Pharmacist involvement in antifungal stewardship programs: a systematic review of clinical, utilization, and economic outcomes. Int J Clin Pharm. 2026 Apr 24.

           https://pubmed.ncbi.nlm.nih.gov/42029838/

• Akman Ar ED, Kara E, Karadoğan E, Ozdede M, Pınar A, Uzun O, Metan G. Towards precision antibiotic therapy: predictors and outcomes of meropenem target attainment. Eur J Hosp Pharm. 2026 Mar 27:ejhpharm-2026-004940.

           https://pubmed.ncbi.nlm.nih.gov/41895816/

• Işık MC, Telli Dizman G, Gül ND, Tekin Demir İ, Aytaç Ak H, Zarakolu P, Metan G. Safety of discontinuing contact precautions in patients with multidrug-resistant bacterial infection or colonization. Acta Microbiol Immunol Hung. 2026 Mar 20:030.2026.02900.

           https://pubmed.ncbi.nlm.nih.gov/41860595/

• Ozturk E, Bali EA, Kiymaz YC, Tepe D, Can IN, Kaya A, Bolataslan BA, Bosnak C, Cunetoglu B, Karasin F, Kutay H, Pekguzel M, Buyukkoruk M, Kuzi S, Usta BA, Agaoglu Y, Irkoren P, Aydın M, Kizmaz YU, Verendag D, Durmusoglu LM, Sonmezer MC, Suntur BM, Parlayan HNK, Kutlu SS, Cinar G, Memikoglu KO, Yavuz SS, Kaya SY, Akhan S, Ergonul O.Clinical and microbiological characteristics of Nocardia infections: a 10-Year multicentre study from Türkiye. Eur J Clin Microbiol Infect Dis. 2026 Mar 25.

           https://pubmed.ncbi.nlm.nih.gov/41879939/

• İnan A, Sayın-Kutlu S, Sönmezer MÇ, Gökengin D.Highlights on HIV Prevention and Antiretroviral Therapy from the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 and Expectations from CROI 2026. Infect Dis Clin Microbiol. 2026 Jan 30;8(1):14-25

           https://pubmed.ncbi.nlm.nih.gov/41809923/

• Akdogan N, Kaymak MK, Bosnak C, Sonmezer MC, Gulmez D, Polat C, Akdagli SA. Clinical Characteristics, Genomic Sequencing, and Treatment Response of 13 Cases Infected With the Emerging Pathogen, Trichopyhton indotineae, From Türkiye. Int J Dermatol. 2026 Jan.

           https://pubmed.ncbi.nlm.nih.gov/41514458/

• Özdemirel HÖ, Tahravi H, Kucukyildirim S, İnkaya AÇ, Mergen H. A novel jumbo phage infecting Pseudomonas aeruginosa: genomic insights and phylogenetic classification. Arch Microbiol. 2026 Apr 24;208(7):357.

           https://pubmed.ncbi.nlm.nih.gov/42029752/

• Özdede M, Balli Turhan FN, Geridönmez Ö, Kara E, Metan G. Comparative nephrotoxicity of polymyxin B versus colistin: evidence from ensemble learning and propensity score matching. J Antimicrob Chemother. 2026 May 5;81(6):dkag044. 

          https://pubmed.ncbi.nlm.nih.gov/42115839/

• Boşnak C, Metan G, Zarakolu P, Karakulak EA, Pınar A, Göker H, Roberts JA, Hernandez-Mitre MP, Akova M. Determinants of levofloxacin prophylaxis failure in high-risk haematology patients: a prospective study integrating resistant colonization and pharmacokinetic/pharmacodynamic target attainment. J Antimicrob Chemother. 2026 Aug 4;81(9):dkag284.

           https://pubmed.ncbi.nlm.nih.gov/42585274/

• Aka N, Işık MC, Pamukçu T, Telli-Dizman G, Batur A, Kaya EK, Hazırolan G, Kılıçaslan B, Uzun Ö, Metan G, Akova M.Infect Dis Clin Microbiol. 2026 Jul 28;8(4):402-412. 

           https://pubmed.ncbi.nlm.nih.gov/42544270/

• Işık MC, Akova M. Pearls and pitfalls of oral carbapenem/penem agents: the promise of a new era or the risk of amplified resistance? Expert Opin Pharmacother. 2026 Aug 22:1-14.

           https://pubmed.ncbi.nlm.nih.gov/42627089/

• Özkocaman V, Kırkızlar TA, Metan G, Uzun Ö, Pınar İE, Özkalemkaş F, Ar MC, Akova M. Management in Patients with Hematological Malignancies: From Primary Prophylaxis to Empirical and Diagnosis-Driven Treatment. Turk J Haematol. 2026 Sep 1;43(3):250-261

           https://pubmed.ncbi.nlm.nih.gov/42535888/

• Plverino E, De Nardo P, Gentilotti E, Górska A, Hotterbeekx A, Keir H, Lacoma A, Rodriguez Ruiz JP, Traversi L, Prat-Aymerich C, Kumar-Singh S, Malhotra-Kumar S, Tonia T, Martin-Loeches I, Cilloniz C, Goossens H, Tacconelli E, Akova M. ERS/ESCMID state-of-the-science statement on the role of rapid diagnostic tests for the diagnosis and management of community-acquired lower respiratory tract infections. Eur Respir J. 2026 Jul 30;68(1):2401601.

           https://pubmed.ncbi.nlm.nih.gov/42532554/

• Neofytos D, Muñoz P, Averbuch D, Mikulska M, Vanbiervliet Y, Baccelli F, Vidal CG, Aguilar-Guisado M, Blijlevens N, Akova M, Calandra T, Cordonnier C.  Non-culture based diagnostic tests for detection of bacterial infections in hematology patients with febrile neutropenia: A review by the European Conference on Infections in Leukemia (ECIL-10). Curr Res Transl Med. 2026 Jun 30;74(3):103600.

           https://pubmed.ncbi.nlm.nih.gov/42435639/

• Sönmezer MÇ, Erul E, Aka Türkmen N, Sahin TK, Demir Cuha M, Hazırolan G, Akova M.Epidemiology and Clinical Profiles of Bacteroides fragilis Bacteremia in a Tertiary Care Setting: A 5-Year Review. Can J Infect Dis Med Microbiol. 2026 Jun 21;2026:5844253.

           https://pubmed.ncbi.nlm.nih.gov/42338515/

• Cidade JP, Póvoa P, Depuydt P, Dhaese S, De Smet K, Tabah A, Akova M, Cotta MO, De Pascale G, Dimopoulos G, Fujitani S, Garnacho-Montero J, Leone M, Lipman J, Ostermann M, Paiva JA, Schouten J, Sjövall F, Timsit JF, Roberts JA, Zahar JR, Zand F, Zirpe K, De Waele JJ, De Bus L; DIANA Study Group.Impact of appropriate antimicrobial therapy on patient outcomes and antimicrobial use: a sub analysis of the DIANA Study Dataset. Intensive Care Med. 2026 Jun;52(6):1196-1209. 

           https://pubmed.ncbi.nlm.nih.gov/42228012/

• Aslan AT, Ezure Y, Tanriverdi ES, Dağ O, Cimen C, Kalem AK, Kayaaslan B, Alkan S, Köylü B, Ata EB, Çağlar B, Saltoğlu N, Önal U, Deniz S, Ural O, Öz M, Bakir M, Yilmaz M, Çakmak R, Batirel A, Akdoğan Ö, Baykam N, Erol Ç, Yanik-Yalçin T, Eren-Kutsoylu OÖ, Türe-Yüce Z, Kalin-Ünüvar G, Özer-Şimşek Z, Güzeldağ S, Köse A, Cihangiroğlu M, Yağci-Caglayik D, Sevinç MB, Aktaş Z, Öncül O, Ersöz G, Kocagöz AS, Hazirolan G, Ünalan-Altintop T, Dinç B, Tüzemen NÜ, Akçali A, Maçin S, Çalişkan A, Hasbek M, Ergon C, Ay-Altintop Y, Şimşek M, Otlu B, Ramsay KA, Harris PNA, Akova M, Paterson DL; Study Group for Carbapenem Resistance (SCARE). Emulating a target trial of early compared with late initiation of appropriate antibiotic therapy for hospital-acquired monobacterial Gram-negative bloodstream infections. J Antimicrob Chemother. 2026 May 5;81(6):dkag161. 

           https://pubmed.ncbi.nlm.nih.gov/42128247/

• van der Schalk TE, Berkell M, Hottebeekx A, Timbermont L, Tabor DE, Lammens C, Recanatini C, Ruzin A, DiGiandomenico A, Jafri H, Chastre J, Esser MT, François B, Bonten MJM, Goossens H, Kluytmans JAJW, Oliver A, Glupczynski Y, Kumar-Singh S, Malhotra-Kumar S; ASPIRE-ICU study team; COMBACTE-MAGNET EVADE study group.Phenotypic convergence and collateral susceptibility development in Pseudomonas aeruginosa under antibiotic exposure in ICU patients. NPJ Antimicrob Resist. 2026 May 8;4(1):38. 

           https://pubmed.ncbi.nlm.nih.gov/42103940/

• Wolfgruber S, Garcia-Vidal C, Sedik S, Salmanton-García J, Arikan-Akdagli S, Gangneux JP, Rautemaa-Richardson R, Arsić-Arsenijević V, Martín-Pérez S, Dávila-Valls J, Erben N, Akalin EH, Drgona L, Lass-Flörl C, García-Rodríguez J, Bicanic T, Hammarström H, Hamal P, Steinmann J, Meijer EFJ, Khanna N, Desoubeaux G, Longval T, Sili U, Trauth J, Bassetti M, White PL, Aujayeb A, Matos T, Akyol D, Danion F, Lagrou K, Rogers B, Ruiz M, Siváková A, Mikulska M, Samarkos M, Blennow O, Lockhart DEA, Denis B, Willinger B, van Dijk K, Scharmann U, Goodman AL, van Praet J, Narayanan M, Toscano C, Loughlin L, de Jonge NA, Ruiz-Gaitan A, Lanternier F, Prattes J, Roilides E, Talento AF, Barac A, Egger M, Arendrup MC, Koehler P, Cornely OA, Hoenigl M; ECMM Candida III study group. Clinical Characteristics, Management and Outcomes of Nonintensive Care Unit Candidemia: Subanalysis of the ECMM Candida III Multinational European Observational Cohort Study. Open Forum Infect Dis. 2026 Mar 26;13(4):ofag133. 

            https://pubmed.ncbi.nlm.nih.gov/41918958/

• Zumbo G, Beltrami M, Bravo-Ferrer JM, Gutiérrez-Gutiérrez B, Rodríguez-Baño J; ASSURE-ID group. Methodological quality assessment tool for observational studies comparing treatment effectiveness in infectious diseases: a Delphi consensus and application to studies on bloodstream infections due to carbapenem-resistant Enterobacterales. Lancet Infect Dis. 2026 Aug;26(8):e285-e293.

           https://pubmed.ncbi.nlm.nih.gov/41887234/

• Balli Turhan FN, Kara E, Şahiner Z, Balci C, Sönmezer MÇ, Inkaya AÇ, Halil MG, Ünal S, Demirkan K. Multidisciplinary Care for Older People With HIV: Optimizing Medication and Enhancing Quality of Life. Open Forum Infect Dis. 2026 Jun 22;13(7):ofag378. 

           https://pubmed.ncbi.nlm.nih.gov/42403909/

• Sokulmez-Yildirim S, Erdem H, Ankarali H, Senbayrak S, Kartal ED, Bayrak O, Poojary A, Darazam IA, Sullu B, Tasbakan M, Kahraman RN, Araz H, Atasoy PY, Roganovic T, Cetin S, Yekenkurul D, Civljak R, Oktay Z, Dogan A, Okay G, Ramosaco E, Pekok AU, Inan-Sarikaya R, Miftode E, Kolovani E, Amer F, Aksoy F, Ghasempour H, Miftode L, Lengerova G, El-Kholy A, Grgic S, Petrov MM, Alkan S, Kotsev S, Peleva MP, Sivrikaya BB, Ipek D, Poposki K, Lanzafame M, Ak O, Yaylaci S, Altindis M, Isik AC, Coskun B, Gurbuz E, Shehata GA, Kaya NK, Bozkurt I, Imre A, Tartar AS, Yildirim C, Dumitru IM, Catalina LM, Belitova M, Taher OMEA, Sari S, Cascio A, Rahimi BA, Karlidag GE, Onofrei MI, Al SO, Kulzhanova S, Cag Y, Ucar HK, Ozmen C, Gherlan GS, Gad MA, Akhtar N, Oncu S, Vieceli T, Konkayev A, Esmaoglu A, Kilavuz A, Bucuk PS, Szabo BG, Davila CG, Semet C, Puca E, Evren EU, Tehrani HA, Angamuthu K, Sonmezer MC, Soysal O, Ates S, Spurio G, Demircan SK, Onder T, Sökmen FC, Rello J, Giammanco A, Fasciana T. Community acquired bacteremia in older adults: International and prospective infectious diseases-international research initiative (ID-IRI) study. Int J Infect Dis. 2026 Aug;169:108767. 

           https://pubmed.ncbi.nlm.nih.gov/42107874

• Clemente T, Stam AJ, Elvstam O, Geretti AM, Harrigan R, Parczewski M, Mackie NE, Spagnuolo V, Hofstra M, Venter F, Kuritzkes DR, Llibre JM, Shafer RW, Schapiro J, Martinez E, Kityo-Mutuluuza C, Nijhuis M, Björkman P, Charpentier C, Collins S, Günthard HF, Cecchini D, Castagna A, Brusselaers N, Wensing AM; International Consensus Group on the Clinical Management of Low-Level Viremia. Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensus. Lancet HIV. 2026 Jul;13(7):e502-e514. 

           https://pubmed.ncbi.nlm.nih.gov/42276093/

• Kırbaş E, Işık MC, Ismayilov R, Ünal S, Sancak B. High prevalence of colistin heteroresistance in Pseudomonas aeruginosa bloodstream isolates and associated clinical factors. Eur J Clin Microbiol Infect Dis. 2026 Jun 24. 

           https://pubmed.ncbi.nlm.nih.gov/42340569/